On March 26, 2024, Edwards Lifesciences Corporation announced that Michael A. Mussallem informed the Board of Directors of his decision to retire as Non-Executive Chairman and a director of the Board which will be effective in conjunction with the Company?s annual meeting of stockholders on May 7, 2024. Therefore, Mr. Mussallem will not stand for election to the Board at the 2024 Annual Meeting. The Company expects to appoint Nicholas J. Valeriani, an independent director, to succeed Mr. Mussallem as Chairman of the Board.

Additionally, Martha H. Marsh has reached the retirement age set forth in the Company?s Corporate Governance Guidelines and will therefore not be nominated to stand for election to the Board at the 2024 Annual Meeting.